An open-label trial of tomoxetine in pediatric attention deficit hyperactivity disorder

Journal of Child and Adolescent Psychopharmacology

Volumn 11, Issue 2, 2001, Pages 167-170

  Kratochvil, C J ^a   Bohac, D ^a   Harrington, M ^a   Baker, N ^a   May, D ^a   Burke, W J ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMOXETINE; NORADRENALIN;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; MULTICENTER STUDY; SCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ANTIDEPRESSIVE AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; PROPYLAMINES; PSYCHIATRIC STATUS RATING SCALES;

EID: 0034960305     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454601750284072     Document Type: Article

References (9)

1. The revised Conners' Parent Rating Scale (CPRS-R): Factor structure, reliability, and criterion validity
2. Parent and teacher ratings of ADHD symptoms: Psychometric properties in a community-based sample
3. CGI, Clinical Global Impression
4. Efficacy of tomoxetine vs. Placebo in pediatric outpatients with ADHD
5. Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder
6. Attention deficit hyperactivity disorder: Advances in cognitive, neurobiological, and genetic research